140 related articles for article (PubMed ID: 20335309)
1. SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.
Puhr M; Santer FR; Neuwirt H; Marcias G; Hobisch A; Culig Z
Endocr Relat Cancer; 2010 Jun; 17(2):525-38. PubMed ID: 20335309
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.
Puhr M; Santer FR; Neuwirt H; Susani M; Nemeth JA; Hobisch A; Kenner L; Culig Z
Cancer Res; 2009 Sep; 69(18):7375-84. PubMed ID: 19738059
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase.
Chikazu D; Hakeda Y; Ogata N; Nemoto K; Itabashi A; Takato T; Kumegawa M; Nakamura K; Kawaguchi H
J Biol Chem; 2000 Oct; 275(40):31444-50. PubMed ID: 10896947
[TBL] [Abstract][Full Text] [Related]
4. Nox2/ROS-dependent human antigen R translocation contributes to TNF-α-induced SOCS-3 expression in human tracheal smooth muscle cells.
Hsu CK; Lee IT; Lin CC; Hsiao LD; Yang CM
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L521-33. PubMed ID: 24414258
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.
Bellezza I; Neuwirt H; Nemes C; Cavarretta IT; Puhr M; Steiner H; Minelli A; Bartsch G; Offner F; Hobisch A; Doppler W; Culig Z
Am J Pathol; 2006 Dec; 169(6):2199-208. PubMed ID: 17148681
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation by zinc of FGF-2-induced VEGF release through enhancing p44/p42 MAP kinase activation in osteoblasts.
Hanai Y; Tokuda H; Yasuda E; Noda T; Ohta T; Takai S; Kozawa O
Life Sci; 2006 Dec; 80(3):230-4. PubMed ID: 17020773
[TBL] [Abstract][Full Text] [Related]
9. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.
Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
Endocr Relat Cancer; 2007 Dec; 14(4):1007-19. PubMed ID: 18045952
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
12. Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells.
Forrai A; Boyle K; Hart AH; Hartley L; Rakar S; Willson TA; Simpson KM; Roberts AW; Alexander WS; Voss AK; Robb L
Stem Cells; 2006 Mar; 24(3):604-14. PubMed ID: 16123385
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
Udayakumar TS; Stratton MS; Nagle RB; Bowden GT
Neoplasia; 2002; 4(1):60-7. PubMed ID: 11922392
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase.
Park J; Gores GJ; Patel T
Hepatology; 1999 Apr; 29(4):1037-43. PubMed ID: 10094943
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.
Souma Y; Nishida T; Serada S; Iwahori K; Takahashi T; Fujimoto M; Ripley B; Nakajima K; Miyazaki Y; Mori M; Doki Y; Sawa Y; Naka T
Int J Cancer; 2012 Sep; 131(6):1287-96. PubMed ID: 22095154
[TBL] [Abstract][Full Text] [Related]
16. Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injury.
Fu XB; Yang YH; Sun TZ; Chen W; Li JY; Sheng ZY
World J Gastroenterol; 2003 Jun; 9(6):1312-7. PubMed ID: 12800247
[TBL] [Abstract][Full Text] [Related]
17. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
Steiner H; Godoy-Tundidor S; Rogatsch H; Berger AP; Fuchs D; Comuzzi B; Bartsch G; Hobisch A; Culig Z
Am J Pathol; 2003 Feb; 162(2):655-63. PubMed ID: 12547723
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
Tokuda H; Kozawa O; Uematsu T
J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the basic fibroblast growth factor-evoked proliferation of the human Müller cell line, MIO-M1.
Hollborn M; Jahn K; Limb GA; Kohen L; Wiedemann P; Bringmann A
Graefes Arch Clin Exp Ophthalmol; 2004 May; 242(5):414-22. PubMed ID: 14963717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
